NJ Court Nixes Trade Secrets Row Over Generic Cough Syrup

Law360, New York (August 27, 2013, 3:56 PM ET) -- A New Jersey appeals court on Tuesday rejected UCB Manufacturing Inc.’s breach of contract and unfair competition claims in its suit accusing a former employee of disclosing confidential information to rival Tris Pharma Inc. to develop a generic version of UCB’s previously patented Tussionex cough medicine.

A three-judge panel of the New Jersey Superior Court’s Appellate Division affirmed a lower court’s 2011 decision granting summary judgment to defendants Tris Pharma and Yu-Hsing Tu, a scientist and drug formulator who worked with UCB’s predecessors from 1990 to...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required